Zhitong Finance App News, Haite Biotech (300683.SZ) issued an announcement. Recently, the company's shareholding company Zhongmou Medical Technology (Wuhan) Co., Ltd. (“Zhongmu Medical”) received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration. Its self-developed clinical trial application for ZM-02 ophthalmic injection has been approved by the State Drug Administration, agreeing to carry out clinical trials for the treatment of advanced retinitis pigmentosa.

Zhitong Finance App News, Haite Biotech (300683.SZ) issued an announcement. Recently, the company's shareholding company Zhongmou Medical Technology (Wuhan) Co., Ltd. (“Zhongmu Medical”) received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration. Its self-developed clinical trial application for ZM-02 ophthalmic injection has been approved by the State Drug Administration, agreeing to carry out clinical trials for the treatment of advanced retinitis pigmentosa.